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Abstract: Vitamin E, such as alpha-tocopherol (ATPH) and alpha-tocotrienol (ATTN), is a 
chain-breaking antioxidant that prevents the chain propagation step during lipid 
peroxidation. In the present study, we investigated the effects of ATTN on KA-induced 
neuronal death using organotypic hippocampal slice culture (OHSC) and compared the 
neuroprotective effects of ATTN and ATPH. After 15 h KA (5 µM) treatment, delayed 
neuronal death was detected in the CA3 region and reactive oxygen species (ROS) 
formation and lipid peroxidation were also increased. Both co-treatment and post-treatment 
of ATPH (100 µM) or ATTN (100 µM) significantly increased the cell survival and 
reduced the number of TUNEL-positive cells in the CA3 region. Increased dichlorofluorescein 
(DCF) fluorescence and levels of thiobarbiturate reactive substances (TBARS) were 
decreased by ATPH and ATTN treatment. These data suggest that ATPH and ATTN 
treatment have protective effects on KA-induced cell death in OHSC. ATTN treatment 
tended to be more effective than ATPH treatment, even though there was no significant 
difference between ATPH and ATTN in co-treatment or post-treatment. 
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1. Introduction 
Kainic acid (KA), an agonist for kainate and alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic 
acid (AMPA) receptors, is an excitatory neurotoxic substance. KA can induce characteristic limbic 
seizures and selective neuronal cell death in both hippocampal CA1 and CA3 regions. The mechanisms 
involved in this pathogenesis appear to be linked to oxidative stress. KA activates the glutamate 
receptor and induces a transmembrane ion imbalance by calcium influx, and then generates the reactive 
oxygen species (ROS). ROS attacks macromolecules within neurons, resulting in membrane lipid 
peroxidation, and structural and functional changes in proteins and DNA strand breaks [1,2]. The brain 
is highly susceptible to oxidative stress because of its high consumption of oxygen energy and glucose, 
large amount of peroxidizable polyunsaturated fatty acid, and relatively low antioxidant capability [3]. 
Increased production of free radicals may play a key role in the neuronal injury caused by KA-induced 
lipid peroxidation. Therefore, scavenging or reducing the KA-induced free radicals is important for 
preventing the harmful insults resulting from KA treatment [4,5]. 
Vitamin E is the term used for a group of tocopherols and tocotrienols, each with alpha, beta, gamma 
and delta analogs, that are essential components of biological membranes where they have both 
antioxidant and non-antioxidant functions [6]. Vitamin E is a chain-breaking antioxidant; it is able to 
repair oxidizing radicals directly, preventing the chain propagation step during lipid peroxidation [7]. In 
the vitamin E group, alpha-tocopherol (ATPH) and alpha-tocotrienol (ATTN) are suggested to have 
the highest biological activity [8,9]. However, the functions of tocotrienols have not been fully 
elucidated. Consistent with the antioxidative effects of tocotrienols, tocotrienol supplementation 
reduces blood levels of lipid peroxides with an improved blood flow in patients with carotid 
atherosclerosis [10]. On the other hand, several reports have suggested that tocotrienols possess  
non-antioxidant functions that contribute to their cholesterol-lowering, anticarcinogenic and 
cytoprotective properties [11–13].  
However, little is known about the effects of tocotrienols on CNS neurons even though there were 
several early reports, which showed a protective role for alpha-tocopherol or vitamin E [14,15]. 
Organotypic hippocampal slice culture (OHSC) models represent a useful intermediate tool for 
studying chronic, progressive cell damage [16]. OHSC models maintain internal structure and function 
as observed in vivo, but allow an examination of the direct effects of excitotoxic compounds on the 
hippocampus that are not possible to study in vivo. In this study, we investigated whether KA-induced 
neuronal death in OHSC can be prevented by ATTN by measuring PI uptake, ROS generation, and 
lipid peroxidation levels and compared the neuroprotective effects of ATTN and ATPH. 
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2. Results and Discussion 
2.1. Effects of ATPH and ATTN on KA-Induced Neuronal Toxicity in OHSC 
PI uptake was measured to assess the effects of ATPH and ATTN on KA-induced cell death. When 
hippocampal slices were exposed to 5 µM KA for 15 h, the PI uptake in the CA3 region was 
significantly higher than that in the CA1 region (Figure 1A). Treatment with ATPH significantly 
reduced the PI uptake at 48 h after treatment as compared to post-treatment with ATPH. Treatment 
with ATTN also showed significantly reduced PI uptake in both co- and post- treatment at 48 h after 
treatment. Thus, co-treatment using ATPH (100 µM) or ATTN (100 µM) with KA significantly reduced 
the level of PI uptake in the CA3 region compared with KA treatment alone (Figure 1B). Further, the 
same trend was also observed with post-treatment using ATPH or ATTN 15 h after KA treatment.  
Figure 1. Effects of alpha-tocopherol (ATPH) and alpha-tocotrienol (ATTN) on KA-induced 
PI uptake in organotypic hippocampal slice culture (OHSC). Representative PI uptake 
images from CONT (untreated), KA (5 µM KA only treated), KA/ATPH Co-treat (100 µM 
ATPH with KA), KA/ATPH Post-treat (100 µM ATPH after KA), KA/ATTN Co-treat 
(100 µM ATTN with KA), and KA/ATTN Post-treat (100 µM ATTN after KA) slices (A). 
Quantification of PI images. Data are presented as means ± S.E.M. of 5 to 7 experiments (B). 
Asterisks (*) indicate statistically significant difference from control (* p < 0.001);  
Sharps (#) indicate statistically significant difference from KA-treated cultures (# p < 0.05). 
Scale bar: 200 µm. 
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2.2. Cresyl Violet Staining and TUNEL Assay  
Slices were stained with cresyl violet in order to measure cell survival and to determine the 
agreement with results from PI and a terminal deoxynucleotidyl transferase-mediated dUTP nickend 
labeling (TUNEL) staining. As shown in Figure 2A, the cresyl violet stained sections showed the  
KA-induced neuronal death was concentrated in the CA3 pyramidal neurons. However, cell death was 
significantly prevented by treatment with ATTP or ATTN (100 µM) compared to treatment with KA 
alone, although there were no statistically significant differences between ATTP and ATTN treatment 
for either co-treatment or post-treatment (Figure 2B). 
Figure 2. Cresyl violet and TUNEL staining in the CA3 region of OHSC. Cresyl violet 
staining was performed at the end of 48 h recovery after KA treatment for 15 h. 
Representative images from CONT (untreated), KA (5 µM KA only treated), KA/ATPH 
Co-treat (100 µM ATPH with KA), KA/ATPH Post-treat (100 µM ATPH after KA), 
KA/ATTN Co-treat (100 µM ATTN with KA), and KA/ATTN Post-treat (100 µM ATTN 
after KA) slices (A and C). Cresyl violet-positive cells regarded as survival cells and 
TUNEL-positive cells indicated as apoptotic cell death were quantified in CA3 region  
(B and D). Data are presented as means ± S.E.M. of 6 experiments for cresyl violet and  
5 experiments for TUNEL staining. Asterisks (*) indicate statistically significant difference 
from control (* p < 0.001 in (B) and * p < 0.001 in (D)); Sharps (#) indicate statistically 
significant difference from KA-treated cultures (# p < 0.05). Scale bar: 200 µm.  
 
Int. J. Mol. Sci. 2013, 14 18260 
 
 
Figure 2. Cont. 
 
To detect DNA fragmentation, TUNEL staining was performed 24 h after KA (5 µM) treatment for 
15 h. KA significantly increased the number of TUNEL-positive cells in the CA3 region compared to 
the control, untreated slice, while 100 µM ATPH and ATTN blocked the response (Figure 2C). With 
both co- and post-treatment with ATPH and KA, the KA-induced neuronal death was significantly 
reduced, even though co-treatment and post-treatment results did not significantly differ. Similar to 
results obtained with ATPH treatment, ATTN treatment also significantly reduced the neuronal death 
with both co- and post-treatment as compared with KA only treatment (Figure 2D). The pattern of PI 
uptake corresponded with the distribution of cell survival detected by cresyl violet staining (Figure 2A) 
and TUNEL staining (Figure 2C). 
2.3. Formation of ROS in KA-Induced Toxicity 
We measured ROS accumulation at the end of the 24-h recovery after KA (5 µM) treatment using 
the fluorescence probe 2',7'-dichlorofluorescein (DCF), which detects intracellular peroxides. Exposure 
of cultures to KA caused a significant increase in DCF fluorescence in all regions of the OHSC 
compared to control (Figure 3A). 100 µM ATPH or ATTN significantly decreased the fluorescence, 
while there were no statistical differences between co-and post-treatment (Figure 3B). The patterns of 
fluorescent images obtained from PI uptake and DCF staining were different. After 24 h of recovery 
following KA treatment, PI fluorescence was clearly evident in the CA3 region, whereas the patterns 
of DCF were more diffuse throughout the whole slice. 
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Figure 3. Effects of ATPH and ATTN on KA-induced increase in DCF fluorescence in 
OHSC. (A) Representative images from CONT (untreated), KA (5 µM KA only treated), 
KA/ATPH Co-treat (100 µM ATPH with KA), KA/ATPH Post-treat (100 µM ATPH after 
KA), KA/ATTN Co-treat (100 µM ATTN with KA), and KA/ATTN Post-treat (100 µM 
ATTN after KA) slices; (B) Quantification of DCF intensity. Data are expressed as 
percentage of control values and are presented as means ± S.E.M. of 5 to 6 experiments. 
Asterisks (*) indicate statistically significant difference from control (* p < 0.05, ** p < 0.001); 
Sharps (#) indicate statistically significant difference from KA-treated cultures (# p < 0.05). 
Scale bar: 200 µm. 
 
2.4. Attenuation of KA-Induced Lipid Peroxidation 
The extent of lipid peroxidation was determined by the concentration of malondialdehyde (MDA), 
which is one of the end products of lipid peroxidation measured by the Thiobarbituric acid reactive 
substances (TBARS) assay. In KA-treated cultures, the levels of MDA were significantly elevated 
relative to those in the controls (Figure 4). After ATPH or ATTN co-treatment or post-treatment with 
KA, MDA levels tended to be lower compared to those in cultures treated with KA only. Moreover, in 
co-treatment or post-treatment of ATPH versus ATTN, although both showed a tendency to reduce 
MDA levels, ATTN showed statistically significant reduction in the level of MDA.  
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Figure 4. Effects of ATPH (A) and ATTN (B) on KA-induced increase in lipid 
peroxidation in OHSC. Lipid peroxidation was measured at 24 h recovery time after drugs 
treatment by TBARS assay as described in Methods. Results are expressed as percentage 
of control values and are means ± S.E.M. of 9 to 12 experiments. Asterisks (*) indicate 
statistically significant difference from control (* p < 0.05); Sharps (#) indicate statistically 
significant difference from KA-treated cultures (# p < 0.05). 
 
2.5. Discussion 
KA treatment with OHSC has been used as an in vitro model to study the mechanisms of status 
epilepticus (SE)-induced neuronal damage and epileptogenesis, since KA treatment of slices induces 
region-specific neuronal death and reorganization of hippocampal circuitry [17,18]. In OHSC, many of 
the excitatory and inhibitory synapses of the transverse hippocampal slice are preserved [19,20]. KA 
induces cell loss in OHSC in a dose-dependent manner [21]. Low concentrations of KA result in a 
specific loss of CA3 neurons, while high concentrations induce complete neuronal death. In our 
previous study [22], we observed the same phenomenon of selective vulnerability in the CA3 region at 
5 µM (low concentration) KA exposure using PI uptake, and the results of cresyl violet and TUNEL 
staining corresponded with the PI results. Neuronal cell death may be caused by excessive ROS, 
mitochondrial dysfunction and caspase activation. Cell death commonly occurs by necrosis or 
apoptosis, although this concept has recently been challenged [23]. Apoptosis is well known to be 
related to increased ROS generation and neurodegeneration. 
Previous studies have shown a time-dependent increase in DCF fluorescence during treatment with 
excitotoxic compounds, with a peak at 0 h recovery after drug exposure that reduces with time [5,24]. 
We observed an increase in DCF fluorescence, which was consistent with the notion that ROS 
accumulation is a cause rather than a consequence of neuronal death. In agreement with these results, 
KA treatment caused a significant increase in DCF fluorescence levels, even at different time points. 
We assessed the production of ROS at 24 h after KA treatment for 15 h. We found that 100 µM of 
ATPH or ATTN significantly inhibited ROS formation compared to KA only-treated cultures.  
Lipid peroxidation by ROS is known to be involved in the damaging mechanism of several acute 
and chronic brain disorders. The most prominent and currently used assay for lipid peroxidation is the 
TBARS assay. It is based on the reactivity of an end product of lipid peroxidation; MDA reacts with 
TBA to produce a red adduct. In ischemic and epileptic studies, lipid peroxidation levels have been 
shown to increase in parts of the brain such as the hippocampus, striatum, and cerebellum [25,26]. In 
Int. J. Mol. Sci. 2013, 14 18263 
 
 
this study, lipid peroxidation levels increased after KA treatment, and this was reduced by ATPH or 
ATTN treatment. Previous studies have shown the disagreement between DCF and TBARS data at 
peak times. DCF fluorescence peaked earlier than lipid peroxidation. This may indicate that lipid 
peroxidation is downstream from ROS generation [27]. Though this mechanism was not exactly 
confirmed by this study, the ability of ATPH and ATTN to inhibit the KA-induced increases in these 
parameters indicates that both ROS formation and MDA release occur downstream of free radical 
production induced by KA. 
ATPH has been found to be effective against ferrous chloride seizures, hyperbaric oxygen seizures, 
and penicillin-induced seizures, where ROS production may have a role in the development of seizures 
itself [28,29]. Vitamin E primarily functions as an antioxidant that reacts with fatty acid peroxyl 
radicals produced from lipid peroxidation. Direct comparisons between the various tocopherol and 
tocotrienol isoforms have shown large differences in antioxidant activity. For many years, ATPH was 
considered the most potent antioxidant against lipid peroxidation in the vitamin E group [30]. 
Recently, however, there has been considerable discrepancy in its relative antioxidant effectiveness 
when compared to other isomers. On one hand, gamma-tocopherol was found to be more potent than 
ATPH particularly in its interaction with reactive nitrogen oxide species [31]. On the other hand, 
ATTN was also found to be a better antioxidant than ATPH [32,33]. Notably, Serbinova et al. [32] 
observed a remarkably higher anti-oxidant activity with tocotrienol against lipid peroxidation in rat 
liver microsomes than with ATPH. Kamat and Devasagayam [34] reported similar results in rat brain 
mitochondria and noted a stronger effect with gamma-tocotrienol. The α-isoforms of tocopherol and 
tocotrienol are the most potent lipid soluble antioxidants due to the level of methylation of the 
chromanol ring, which greatly improves the reactivity of the hydroxyl group and facilitates the transfer 
of the hydrogen to a peroxyl radical to form a tocopheroxyl or tocotrienoxyl radical [35]. Tocopherols 
and tocotrienols can be restored by reduction of tocopheroxyl and tocotrienoxyl radical by other 
antioxidants such as vitamin C and ubiquinol [36,37]. The antioxidant potencies of tocopherols and 
tocotrienols have been compared in a variety of extensive in vitro studies, and the results showed that 
tocotrienols have a higher free radical scavenging efficiency than tocopherols. Moreover, there are a 
limited number of studies about tocotrienols as an antioxidant in vivo, and also many studies have 
shown the effects of pre-treatment with vitamin E analogs. In the present study, we investigated the 
effects of ATPH and ATTN on KA-induced neuronal death in OHSC. There was a marked difference 
in the time course of these treatments as compared with previous studies. 100 µM ATPH and ATTN 
treatment dramatically protected pyramidal cells of CA3 against KA treatment, as based on results 
from PI uptake, cresyl violet staining, and TUNEL assay. In addition, ATPH and ATTN attenuated 
KA-induced ROS generation and lipid peroxidation. ATTN tends to have a more protective effect than 
ATPH on KA-induced neurotoxicity even though there was significant difference between ATPH and 
ATTN in co-treatment or post-treatment. 
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3. Experimental Section 
3.1. Organotypic Slice Culture 
All animal experiments were approved by the Institutional Animal Care and Use Committee of 
Yonsei University Health System. OHSC was conducted in accordance with our previous experimental 
protocols [5,18,22,24] modified from Stoppini et al. [38]. In brief, we rapidly removed hippocampi 
from seven-day-old Sprague-Dawley rat pups and transferred them to cold dissection media comprised 
of Gey’s balanced salt solution (Sigma, St. Louis, MO, USA) with 0.5% glucose and 3 mM KCl. 
Sections were cut to 350 µm with a McIlwain tissue chopper (Vibratome, O’Fallon, MO, USA) and 
inspected and cut into slices under a dissection microscope. After inspection, six slices were 
transferred onto a Millicell-CM membrane insert (Millipore, Billreka, MA, USA) set on a 6-well plate 
in 1 mL of culture medium composed of 50% Opti-MEM, 25% Hank’s balanced salt solution (HBSS), 
25% heat-inactivated horse serum, 6.5 mg/mL D-glucose (AMRESCO Inc., Solon, OH, USA), pH 7.2 
(all from Gibco BRL, Grand Island, NY, USA). Plates were kept in a 35 °C humidified incubator with 
5% CO2. The media was changed three times a week. Slices were grown for 20–24 days in vitro (DIV) 
prior to drug treatment. 
3.2. Drug Treatment and Assessment of Neuronal Injury  
KA (5 µM) was applied for 15 h in OHSC. Stock solutions (103× working concentration, 100 mM) of 
α-tocopherol (ATPH, Sigma, St. Louis, MO, USA) and α-tocotrienol (ATTN, Tocomin®, Kind gift from 
Carotech Berhad, Perak, Malaysia) were prepared in ethanol. Co-treatment was performed ATPH  
(100 µM) or ATTN (100 µM) were simultaneously added to the culture dishes with KA for 15 h  
(co-treatment) and changed culture medium obtained ATPH or ATTN. The post-treatment was 
conducted the ATPH or ATTN was treated for 24 h and 48 h after withdraw of the KA treatment for  
15 h. These concentrations were chosen based on the maximal effects obtained in preliminary tests. For 
detection of neuronal cell death, cellular uptake of the fluorescent dye propidium iodide (PI, Sigma,  
St. Louis, MO, USA) was recorded. PI is basically nontoxic to neurons and has been used as an  
indicator of neuronal membrane and cell damage. PI was added to the culture medium to achieve a final 
concentration of 5 µg/mL. PI uptake was recorded by fluorescence microscopy (IX-71, Olympus, Tokyo, 
Japan) using a standard rhodamine filter and digital camera and then analyzed with the MetaMorph 
Imaging System (Universal Imaging, Downingtown, PA, USA).  
3.3. Cresyl Violet Staining and TUNEL Assay  
For histological experiments, slices were rinsed in PBS twice, fixed with cold 4% paraformaldehyde 
for 30 min, and stored in 30% sucrose at 4 °C overnight. Sections were cut with a cryostat at a 
thickness of 10 µm. Only sections from the middle to the upper part of the culture were used since 
these sections were similar. Cresyl violet staining was performed after 48 h of recovery time following 
KA treatment with ATPH or ATTN, and photomicrographs were taken at 10× magnification. The 
numbers of positive cells in CA3 region were counted using the MetaMorph Imaging system 
(Universal Imaging, Downingtown, PA, USA) by outlining the CA3 pyramidal cell layer. The mean 
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value of three sections per slide for each group was used in different experiments. Apoptosis was 
assessed using the in situ apoptosis detection kit (ApopTag® Plus Peroxidase In Situ Apoptosis 
Detection kit, Chemicon, Temecula, CA, USA). A TUNEL assay was performed 24 h after drugs 
exposure. Photomicrographs were taken at 10× magnification. Positive TUNEL staining was 
quantified in the same way as cresyl violet. 
3.4. Evaluation of Intracellular ROS Formation  
Formation of intracellular peroxides was detected using an oxidant-sensing fluorescent probe,  
2',7'-dichlorofluorescin diacetate (DCFH-DA, Sigma, St. Louis, MO, USA). DCFH-DA is  
cell-membrane permeable, and it is converted to 2',7'-dichlorofluorescin (DCFH), which interacts with 
intracellular free radicals and peroxides to become fluorescent 2',7'-dichlorofluorescein (DCF). 10 µM 
DCF-DA was applied to the culture medium at 35 °C for 30 min, and then the cultures were washed 
twice with phosphate-buffered saline (1× PBS, pH 7.4). The fluorescent DCF was detected using a 
fluorescence microscope (IX-71, Olympus, Tokyo, Japan), captured by a digital camera, and quantified 
using the MetaMorph Imaging System (Universal Imaging, Downingtown, PA, USA). 
3.5. Lipid Peroxidation-TBARS Assay 
Lipid peroxidation was measured using the OxiSelect™ TBARS Assay Kit (Cellbiolabs, San 
Diego, CA, USA) according to the manufacturer’s protocol. In brief, cultured slices were homogenized 
in a lysis buffer. Homogenates (100 µL) were mixed with a color reagent consisting of thiobarbituric 
acid (TBA), acetic acid and sodium hydroxide. The mixture was incubated at 95 °C for 1 h and 
centrifuged at 3000 rpm for 10 min. TBARS were measured by the absorbance at 532 nm. Data were 
calculated from MDA standard curve. 
3.6. Statistical Analysis  
Statistical calculations were performed using SPSS statistical program (SPSS Inc., Chicago, IL, 
USA). Results are expressed as mean ± S.E.M. Differences among groups were analyzed by Dunnett’s 
post-hoc test. The level of significance was accepted at p < 0.05. 
4. Conclusions 
The delayed and selective neuronal death in the CA3 area of OHSC after KA treatment was observed. 
KA treatment also caused the levels of DCF fluorescence and MDA to increase significantly. However, 
ATTN as well as ATPH prevented neuronal damage and reduced the ROS formation and lipid 
peroxidation compared to KA only-treated cultures. These results indicate that ATTN as a free radical 
scavenger such as ATPH has protective effects against cell death by KA in OHSC.  
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